These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6278198)

  • 1. [Encephalitis following measles-mumps vaccination simultaneous to an EBV-infection (author's transl)].
    Forster J; Urbanek R
    Klin Padiatr; 1982 Jan; 194(1):29-30. PubMed ID: 6278198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination: I. What has proved useful? (author's transl)].
    Spiess H
    MMW Munch Med Wochenschr; 1979 Apr; 121(14):489-92 contd. PubMed ID: 107439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
    Gans H; Yasukawa L; Rinki M; DeHovitz R; Forghani B; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2001 Oct; 184(7):817-26. PubMed ID: 11528592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
    Samoilovich EO; Kapustik LA; Feldman EV; Yermolovich MA; Svirchevskaya AJ; Zakharenko DF; Fletcher MA; Titov LP
    Cent Eur J Public Health; 2000 Aug; 8(3):160-3. PubMed ID: 10965439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles and mumps immunization: benefit versus risk factors.
    Krugman S
    Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
    Buxbaum S; Doerr HW; Allwinn R
    Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protracted mumps encephalitis with good outcome.
    Kim P; Cappelen-Smith C
    J Clin Neurosci; 2005 Nov; 12(8):959-61. PubMed ID: 16257214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern trends in vaccination policy: evaluation of benefits, risks and cost (author's transl)].
    Wiedermann G
    Wien Klin Wochenschr; 1979 Mar; 91(5):143-50. PubMed ID: 106558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fulminant cerebello-brainstem encephalitis with polyradiculitis following probable Epstein-Barr virus infection].
    Koguchi Y; Yagishita T; Sato A; Watanabe Y
    Rinsho Shinkeigaku; 1996 Nov; 36(11):1225-8. PubMed ID: 9046853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects of the use of the preventive mixed mumps, rubella and measles vaccine inchildren of the City of São Paulo].
    Konichi SR; Laus WC; Mattos CA; Amato Neto V; Aly J; Finger H; Bianchi A
    Rev Inst Med Trop Sao Paulo; 1973; 15(3):161-4. PubMed ID: 4732747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.